• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液中全基因组cfDNA片段化模式反映髓母细胞瘤分组。

Genome-wide cfDNA fragmentation patterns in cerebrospinal fluid reflect medulloblastoma groups.

作者信息

Markowitz Alexander L, Munugula Chetan, Christodoulou Eirini, Ji Jianling, Xu Liya, Cotter Jennifer A, Yellapantula Venkata

机构信息

Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

出版信息

NPJ Precis Oncol. 2025 Aug 12;9(1):280. doi: 10.1038/s41698-025-01067-5.

DOI:10.1038/s41698-025-01067-5
PMID:40796676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12343951/
Abstract

Identifying molecular groups in medulloblastoma currently requires invasive biopsies for accurate diagnosis. We analyzed cerebrospinal fluid cell-free DNA (cfDNA) fragmentation patterns in 122 samples as a minimally-invasive alternative. Our analysis confirmed established group-specific copy number alterations and identified distinct fragmentation patterns for each group. Our integrated meta-classifier achieved high accuracy (mean-AUC 0.94) in distinguishing the four molecular groups, demonstrating cfDNA fragmentomics' potential for improving diagnosis and personalized treatment strategies.

摘要

目前,要确定髓母细胞瘤中的分子组需要进行侵入性活检才能准确诊断。我们分析了122份样本中的脑脊液游离DNA(cfDNA)片段化模式,作为一种微创替代方法。我们的分析证实了既定的组特异性拷贝数改变,并确定了每组不同的片段化模式。我们的综合元分类器在区分这四个分子组方面达到了很高的准确率(平均AUC为0.94),证明了cfDNA片段组学在改善诊断和个性化治疗策略方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/9ee9c52f9b80/41698_2025_1067_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/253646fe8ec1/41698_2025_1067_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/eeac8d072a1e/41698_2025_1067_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/5a1f77fae293/41698_2025_1067_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/9ee9c52f9b80/41698_2025_1067_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/253646fe8ec1/41698_2025_1067_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/eeac8d072a1e/41698_2025_1067_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/5a1f77fae293/41698_2025_1067_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4c/12343951/9ee9c52f9b80/41698_2025_1067_Fig4_HTML.jpg

相似文献

1
Genome-wide cfDNA fragmentation patterns in cerebrospinal fluid reflect medulloblastoma groups.脑脊液中全基因组cfDNA片段化模式反映髓母细胞瘤分组。
NPJ Precis Oncol. 2025 Aug 12;9(1):280. doi: 10.1038/s41698-025-01067-5.
2
Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort.用于真实世界儿科脑肿瘤队列中肿瘤检测与特征分析的超低输入量游离DNA测序
Acta Neuropathol Commun. 2025 Jun 28;13(1):134. doi: 10.1186/s40478-025-02024-w.
3
Cell-free epigenomes enhanced fragmentomics-based model for early detection of lung cancer.基于无细胞表观基因组增强片段组学的肺癌早期检测模型
Clin Transl Med. 2025 Feb;15(2):e70225. doi: 10.1002/ctm2.70225.
4
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients.从脑肿瘤患者的脑脊液游离 DNA 中检测诊断性体细胞拷贝数改变。
Acta Neuropathol Commun. 2024 Nov 20;12(1):177. doi: 10.1186/s40478-024-01887-9.
5
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
6
cfDNAFE: Comprehensively extracting multi-omics features of cell-free DNA for noninvasive diagnosis.cfDNAFE:用于无创诊断的游离DNA多组学特征综合提取法
Methods. 2025 Sep;241:163-172. doi: 10.1016/j.ymeth.2025.05.013. Epub 2025 Jun 3.
7
Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response.用于鉴别乳腺结节恶性程度及评估治疗反应的游离DNA片段组学检测
Genomics Proteomics Bioinformatics. 2025 May 30;23(2). doi: 10.1093/gpbjnl/qzaf028.
8
Genome-Wide cfDNA Methylation Profiling Reveals Robust Hypermethylation Signatures in Ovarian Cancer.全基因组cfDNA甲基化分析揭示卵巢癌中强大的高甲基化特征
Cancers (Basel). 2025 Jun 17;17(12):2026. doi: 10.3390/cancers17122026.
9
Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA Methylome.基于肿瘤来源特征和 cfDNA 甲基组学的非小细胞肺癌亚型分类
Cancer Res Commun. 2024 Jul 1;4(7):1738-1747. doi: 10.1158/2767-9764.CRC-23-0564.
10
Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases.基于纳米孔的肺癌脑转移患者脑脊液中游离DNA片段化和甲基化图谱
bioRxiv. 2025 Jul 31:2025.07.28.667300. doi: 10.1101/2025.07.28.667300.

本文引用的文献

1
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis.在诊断时循环无细胞肿瘤 DNA 水平较高与疾病扩散相关,并定义了预后不良的多发性骨髓瘤患者。
Blood Cancer J. 2024 Nov 28;14(1):208. doi: 10.1038/s41408-024-01185-6.
2
Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application.cfDNA 和 ctDNA 在提高子宫内膜癌患者风险分层和疾病随访中的作用:迈向临床应用。
J Exp Clin Cancer Res. 2024 Sep 20;43(1):264. doi: 10.1186/s13046-024-03158-w.
3
Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns.
胚系 TP53 突变携带者的无细胞 DNA 反映出类似癌症的碎片化模式。
Nat Commun. 2024 Aug 27;15(1):7386. doi: 10.1038/s41467-024-51529-w.
4
Medulloblastoma subgrouping at first sight.髓母细胞瘤亚组一览。
Cancer Cell. 2024 Jul 8;42(7):1154-1157. doi: 10.1016/j.ccell.2024.06.011.
5
Disease Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies in Two Cases of Recurrent Medulloblastoma.两例复发性髓母细胞瘤患者通过连续脑脊液液体活检监测疾病演变。
Int J Mol Sci. 2024 Apr 30;25(9):4882. doi: 10.3390/ijms25094882.
6
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
7
Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors.小儿中枢神经系统肿瘤患者脑脊液游离DNA的低通全基因组和靶向测序
Neurooncol Adv. 2023 Jun 28;5(1):vdad077. doi: 10.1093/noajnl/vdad077. eCollection 2023 Jan-Dec.
8
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs.通过末端基序去卷积分析揭示无细胞 DNA 的碎片化景观。
Proc Natl Acad Sci U S A. 2023 Apr 25;120(17):e2220982120. doi: 10.1073/pnas.2220982120. Epub 2023 Apr 19.
9
Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors.小儿实体瘤液体活检中的联合低通全基因组和靶向测序
NPJ Precis Oncol. 2023 Feb 20;7(1):21. doi: 10.1038/s41698-023-00357-0.
10
Epigenetic analysis of cell-free DNA by fragmentomic profiling.基于片段组学分析的游离 DNA 表观遗传学分析。
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2209852119. doi: 10.1073/pnas.2209852119. Epub 2022 Oct 26.